In mild cases, ECM dysregulation is associated with decreased levels of calmodulin, galectin, and lumican, which are involved in muscle homeostasis and repair and could be possible targets for FSHD treatments [50,51,52,53,54]. Here, LUM is linked to Facioscapulohumeral dystrophy.